Buprenorphine: Clinical and Public Policy Implications (BUPE2021)
Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the posttest, evaluation and claim your credit on the following page.
BUPE2021 is a “virtual resource” that is an extension of Journal of Opioid Management’s Special Issue on Buprenorphine. More than a conference, BUPE2021 is a resource for those looking to learn about this interesting molecule. Presentations will be available through the end of March 2022.
Physicians, nurses, pharmacists
Objectives: After attending this meeting participants should be able to:
- Describe the therapeutic benefits of buprenorphine and highlight indications for its use in acute, chronic and cancer pain.
- Explain interactions of buprenorphine with other opioids.
- Explain the appropriate application of buprenorphine in pain patients and those with co-morbid substance use disorder.
- Explain the concepts and practice of micro-dosing, rotation and titration.
- Recognize the legal and regulatory implications of prescribing opioids that arise when treating individuals in pain.
- Explain the basic pharmacology of buprenorphine and utilize and promote evidence-based approaches for clinical treatment.
- Describe the various delivery methods for buprenorphine in the management of pain.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine Continuing Nursing Education and Weston Medical Publishing. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 9.00 AMA PRA Category 1 Credit™Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 9.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 9.00 Participation